Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Rachel Piacsek

Nurse Practitioner Richmond, KY Nurse Practitioner

NPI 1588187470 CMS profile 10591102

789 Eastern Byp Ste 16, Richmond, KY 40475

Open in the dashboard

General payments

$16,976

411 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rachel Piacsek of Richmond, KY is reported in the CMS Open Payments database as having received $16,976 across 411 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $33 2
2024 General $47 3
2023 General $2,764 22
2022 General $10,641 213
2021 General $3,492 171

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rachel Piacsek
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Rachel Piacsek were reported at $33. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Rachel Piacsek Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $3,492 $135 $40–$426 $132
2022 $10,641 $152 $48–$470 $149
2023 $2,764 $166 $54–$529 $160
2024 $47 $173 $55–$556 $164
2025 $33 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $11,404 116 payments
  2. Biohaven Pharmaceuticals, Inc. $1,129 51 payments
  3. Biohaven Pharmaceutical Holding Company Ltd. $899 60 payments
  4. UCB, Inc. $552 35 payments
  5. SK Life Science, Inc. $484 14 payments
  6. Amgen Inc. $321 15 payments
  7. Sunovion Pharmaceuticals Inc. $202 17 payments
  8. Lilly USA, LLC $201 12 payments
  9. Teva Pharmaceuticals USA, Inc. $175 9 payments
  10. Allergan Inc. $173 13 payments
  11. Other $1,436 69 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,888 10 payments
  2. Food and Beverage $7,886 397 payments
  3. Travel and Lodging $193 3 payments
  4. Education $10 1 payment
Products named General payments · program years 2021–2025
  1. UBRELVY $9,460 77 payments
  2. QULIPTA $3,946 29 payments
  3. NURTEC ODT $2,028 111 payments
  4. AIMOVIG $393 16 payments
  5. Briviact $385 21 payments
  6. XCOPRI $300 3 payments
  7. BOTOX Hyperhydrosis $211 14 payments
  8. APTIOM $210 18 payments
  9. BOTOX Facial Aesthetics $165 8 payments
  10. VYEPTI $163 3 payments
  11. Other $2,071 122 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

411 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record